Waki Kayo, Tamura Sumihito, Sugawara Yasuhiko, Yamashiki Noriyo, Kadowaki Takashi, Kokudo Norihiro
Terasaki Foundation Laboratory, Los Angeles, California, USA.
Clin Transpl. 2009:55-64.
This chapter summarizes analyses of 51,060 adult primary liver-only transplants from deceased donors reported to the OPTN/UNOS Liver Transplant Registry from 1995 to 2009. Despite advances in surgical techniques and immunosuppression, analysis shows improvement in one-year graft but no improvement in long-term graft survival. Adoption of the Model for End-Stage Liver Disease (MELD) score for organ allocation--prioritizing sicker patients for transplantation--has significantly influenced liver transplant procedures. Accordingly, we classified the transplants into two groups: 1995-2001 (pre-MELD era) and 2002-2007 (MELD era), and our analyses found that long-term survival of liver grafts remained almost unchanged between the two eras. Patient pre-transplant status was better in the MELD era. But when we analyzed the grafts that survived more than one year, survival rates were slightly better pre-MELD than in the MELD era (82.2% and 80.34%, respectively) and risk of graft failure was slightly higher in the MELD era. This chapter also provides analyses of current graft survival rates for 10 different primary liver diseases. Hepatocellular carcinoma, hepatitis C virus cirrhosis, and alcoholic liver disease account for almost 50 % of the primary diseases, and have worse graft survival than the other primary diseases. The lack of improvement in long-term survival suggests an on-going need for means to avoid chronic liver graft dysfunction and to develop therapeutic interventions to control chronic graft loss.
本章总结了1995年至2009年向器官获取与移植网络/器官共享联合系统肝脏移植登记处报告的51,060例来自已故供体的成人单纯肝移植分析。尽管手术技术和免疫抑制有所进步,但分析显示一年期移植物有改善,但长期移植物存活率没有提高。采用终末期肝病模型(MELD)评分进行器官分配——优先考虑病情较重的患者进行移植——对肝移植程序产生了重大影响。因此,我们将移植分为两组:1995 - 2001年(MELD时代之前)和2002 - 2007年(MELD时代),我们的分析发现两个时代之间肝移植物的长期存活率几乎没有变化。MELD时代患者移植前状况更好。但当我们分析存活超过一年的移植物时,MELD时代之前的存活率略高于MELD时代(分别为82.2%和80.34%),且MELD时代移植物失败风险略高。本章还提供了10种不同原发性肝病当前移植物存活率的分析。肝细胞癌、丙型肝炎病毒肝硬化和酒精性肝病占原发性疾病的近50%,且移植物存活率比其他原发性疾病更差。长期存活率缺乏改善表明持续需要采取措施避免慢性肝移植物功能障碍,并开发治疗干预措施来控制慢性移植物丢失。